CClinicalTrials.gg
CompletedNCT02152176TACIDOUUpdated Jun 30, 2016

Morphine Titration by Patient Self-controlled by a Mechanical Device Versus Administration by the Nurse for Patients With Severe Acute Pain in the Emergency Department

A Phase 4 interventional study of Titration of morphine by Patient Controlled Analgesy in Acute Pain, sponsored by University Hospital, Angers. Completed at 2 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-06-30.

Sponsored by University Hospital, Angers · Phase 4, Interventional, and Treatment

Phase
Phase 4
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Intense acute pain is a common reason for Emergency admittance and its management is one of the major public health goals.

In the recommendations formalized experts, it is recommended to use a protocol titration with morphine bolus of 2 mg (for patients less than 60 kg) or 3 mg (for patients over 60 kg) repeated every 5 minutes with a target of the Visual Analog Scale less than or equal to 30.

Despite these specific recommendations and a broad awareness of the teams, management of pain remains to be improved, the major difficulty of morphine titration at the emergency department being the availability of paramedical personnel to perform revaluations and reinjection. Thus, effective analgesia would be obtained in 50% of cases to 30 minutes.

The investigators want to study the self-controlled morphine titration by the patient by a mechanical device for single use (efficacy/safety).

02

Conditions studied

  • Acute Pain

Browse trials for

Keywords

  • pain
  • analgesia
  • morphine
  • PCA
  • Nurse
03

In context

Acute Pain

876 studies on the registry are indexed under Acute Pain; 154 are open to participants now.

This study's enrollment of 200 is above the median of 90 across 732 interventional studies indexed under Acute Pain.

Browse Acute Pain studies →

Lead sponsor

University Hospital, Angers is the lead sponsor of 464 studies on the registry; 116 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Admission to an emergency department
  • Acute pain (Visual Analog Scale > 60)
  • Able to assess pain using the numerical scale
  • Prescription of morphine titration

Exclusion criteria

Exclusion Criteria:

  • Physical or mental disorders limiting the understanding and / or use of a PCA
  • History of allergy to morphine / hypersensitivity to any component
  • Long-term treatment morphine
  • Opioid therapy administered prior to inclusion
  • Analgesic treatment level 2 (codeine, tramadol, nefopam ...) administered prior to inclusion or planned
  • History of Substance Abuse
  • Severe respiratory insufficiency
  • Severe hepatic impairment
  • Head trauma
  • Intracranial hypertension
  • Uncontrolled epilepsy
  • Pregnant or lactating
  • Patient jailed
  • Incapacitated adult under guardianship
  • Incapable of giving informed consent
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
200 participants (actual)

Study arms

  • Experimental
    Patient Controlled Analgesy group

    Titration of morphine by Patient Controlled Analgesy. The opioid titration will be performed by the patient using PCA (Vygon Freedom 5) according to the principle of self with a refractory period of 5 minutes.

    Device: Titration of morphine by Patient Controlled Analgesy

  • No intervention
    Control group

    titration will be perform in the usual manner in accordance with the recommendations : a nurse will assess pain using a visual analog scale in the control group to assess the need for a new bolus of morphine

Interventions

  • DeviceTitration of morphine by Patient Controlled Analgesy

    PCA is never used for titration but only for relay of titration. Self-controlled analgesia by PCA is our intervention.

06

What researchers measure

Primary outcomes

  1. Visual Analog Scale <30

    Evaluate the effectiveness of the analgesia of morphine titration self-controlled by the patient using a PCA device for single use ("PCA" group) opposing to an opioid titration carried out by the nurse (group 'Control')

    Time frame: 30min

Secondary outcomes

  1. Evaluate the effectiveness in the group Patient Controlled Analgesy

    * time to obtain effective analgesia from prescirption * consumption of morphine * Visual Analog Scale evolution * percentage of patients relieved defined by VAS \<40, 1 hour after the prescription of opioid titration

    Time frame: 4h

  2. Satisfaction

    * patient satisfaction * nurse satisfaction * time to prepare morphine titration

    Time frame: 4h

Other outcomes

  1. Assess the safety in the group Patient Controlled Analgesy

    * adverse events du to morphine * adverse events du to medical/nursing support

    Time frame: 4h

07

Study locations

2 sites
  • SCHOTTE Thibault
    Angers, 49933, France
  • CHOUKROUN Jacques
    Le Mans, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 30, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02152176
Lead sponsor
University Hospital, Angers
Responsible party
Sponsor
First posted
Jun 2, 2014
Start date
Jul 2014
Primary completion
Feb 2016
Completion
Feb 2016
Last update
Jun 30, 2016

Study contacts

ROY Pierre-Marie, MD-PhD
study chair · UH Angers
SCHOTTE Thibault, Physician
principal investigator · UH Angers

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion